Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

Below, you can read about the amicus brief — also known as a “friend of the court” brief —APC submitted last week in a compounding-related case pending in the U.S. Fifth Circuit Court of Appeals. It’s a big deal, so please pay attention to it.

That filing is the first of a half-dozen “big deals” that APC will announce in the next three weeks, every one of them focused one way or another on assuring your patients can continue to access compounded drugs, assuring your pharmacy or facility stays scrupulously compliant, and assuring your practice can operate at maximum efficiency.

The other five “big deals” will be rolled out at APC’s Owner Summit in La Jolla, California on April 5. 

BY THE WAY: This is shaping up to be our biggest Owner Summit ever, with more than 200 attendees already signed up. If you’re not one of those, there’s still time to register — but hurry: As you’ll read below, the preferred hotel rate ends tonight.

Those include announcement (and discussion!) of the following:

• Best Practices for Ketamine Compounding, a document developed by APC’s Best Practices Work Group.
• Best Practices for Clinic Direct Billing, another document developed by that Best Practices Work Group.
• APC’s 2023-24 Snapshot of Pharmacy Compounding, a demographic profile of your profession that we’ll use to educate policymakers.
• A step forward in collecting patient-reported outcomes, featuring the first full integration of a compounding software with the OutcomeMD platform (and what may be a work-around solution for those of you using other software).
• A new, simpler way to support APC — and stop all those fundraising emails we keep sending you. 

Hopefully, your curiosity is piqued. If you want to know more, get registered for Owner Summit. Because these are big deals, and you’re gonna want to know about them.

Stay tuned and stay informed!

— Joe

Joseph P. Navarra, RPh, FACA, FAPC is the owner of Town Total Compounding Center in Woodbury, New York. You can reach him at joseph.navarra@towntotalcompound.com.